Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Alberghini

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The American Journal of Pathology|July 31, 2010
Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical studyJozef Zustin, Hana Akpalo, Marco Gambarotti, et al.
BMC Cancer|November 4, 2011
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcomaFilomena de Nigris, Licciana Zanella, Francesco Cacciatore, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2011
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalKatia Scotlandi, Maria Cristina Manara, Massimo Serra, et al.
The American Journal of Surgical Pathology|April 28, 2010
A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of boneSofie L J Verbeke, Christopher D M Fletcher, Marco Alberghini, et al.
International Journal of Cancer|June 23, 2009
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)Diana Zambelli, Monia Zuntini, Filippo Nardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1Stefano Ferrari, Pietro Ruggieri, Graziella Cefalo, et al.
American Journal of Clinical Oncology|March 8, 2013
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutionsEmanuela Palmerini, Robert G Maki, Eric L Staals, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2009
Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical supportAntonio Llombart-Bosch, Isidro Machado, Samuel Navarro, et al.
European Journal of Radiology|September 14, 2010
Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 casesEugenio Rimondi, Giuseppe Rossi, Tommaso Bartalena, et al.
Clinical Sarcoma Research|May 17, 2012
Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic featuresFredrik Mertens, Salvatore Romeo, Judith Vmg Bovée, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The American Journal of Pathology|July 31, 2010
Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical studyJozef Zustin, Hana Akpalo, Marco Gambarotti, et al.
BMC Cancer|November 4, 2011
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcomaFilomena de Nigris, Licciana Zanella, Francesco Cacciatore, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2011
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalKatia Scotlandi, Maria Cristina Manara, Massimo Serra, et al.
The American Journal of Surgical Pathology|April 28, 2010
A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of boneSofie L J Verbeke, Christopher D M Fletcher, Marco Alberghini, et al.
International Journal of Cancer|June 23, 2009
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)Diana Zambelli, Monia Zuntini, Filippo Nardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1Stefano Ferrari, Pietro Ruggieri, Graziella Cefalo, et al.
American Journal of Clinical Oncology|March 8, 2013
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutionsEmanuela Palmerini, Robert G Maki, Eric L Staals, et al.
Virchows Archiv : an International Journal of Pathology|October 21, 2009
Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical supportAntonio Llombart-Bosch, Isidro Machado, Samuel Navarro, et al.
European Journal of Radiology|September 14, 2010
Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 casesEugenio Rimondi, Giuseppe Rossi, Tommaso Bartalena, et al.
Clinical Sarcoma Research|May 17, 2012
Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic featuresFredrik Mertens, Salvatore Romeo, Judith Vmg Bovée, et al.
Pageof 7